Immunotherapy is gaining ground in cancer treatment, but there is still a long way to go until we can manage to improve immune system-boosting drugs to be effective against different types of tumors. Could newly designed, drug-carrying nanoparticles be the answer to better immunotherapy? (Source: medicalnewstoday.com)

Though you may not hear of it often, cytomegalovirus is a fairly common virus. It is usually harmless, but once contracted, it remains in the system for the rest of a person's life. (Source : medicalnewstoday.com)

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source : .reuters.com)